Nuvation Bio Inc. (NUVB) — Financial statements
Income statement, balance sheet, and cash flow for Nuvation Bio Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 63↑699.0% | 8 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 8↑19.3% | 7 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 54↑6750.3% | 0.80 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 115↓78.0% | 524↑635.3% | 71↓18.8% | 88↑27.2% | 69 | |
| General & Administrative Expenses | 0.00↓100.0% | 67↑133.9% | 29↓10.6% | 32↑31.5% | 24 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 3 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 152↑118.9% | 69↑142.6% | 29↓10.6% | 32↑31.5% | 24 | |
| Other Expenses | 0.86 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 268↓54.9% | 593↑494.5% | 100↓16.6% | 120↑28.3% | 93 | |
| Total Costs & Expenses | 276↓54.0% | 601↑501.6% | 100↓16.6% | 120↑28.3% | 93 | |
| Operating Results | ||||||
| Operating Income | -213↑64.0% | -593↓493.7% | -100↑16.6% | -120↓28.3% | -93 | |
| Depreciation & Amortization | 0.00↓100.0% | 0.68↑207.7% | 0.22↑11.6% | 0.20↑8.2% | 0.18 | |
| EBITDA | -191↑66.3% | -567↓650.1% | -76↑36.8% | -120↓28.3% | -93 | |
| EBIT | -191↑66.4% | -568↓648.8% | -76↑36.7% | -120↓28.3% | -93 | |
| Interest & Other Income | ||||||
| Net Interest Income | 8↓71.0% | 27↑8.6% | 25↑230.4% | 7↑151.4% | 3 | |
| Interest Income | 21↓20.8% | 27↑10.0% | 25↑230.4% | 7↑151.4% | 3 | |
| Interest Expense | 14↑3912.3% | 0.34 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | -22↑11.6% | -25↓4.2% | -24 | 0.00 | 0.00 | |
| Other Income / Expenses | 8↓65.8% | 25↑2.8% | 24↑54.6% | 16↑140.1% | 6 | |
| Income Before Tax | -205↑64.0% | -568↓649.2% | -76↑27.3% | -104↓20.0% | -87 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -205↑64.0% | -568↓649.2% | -76↑27.3% | -104↓20.0% | -87 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -205↑64.0% | -568↓649.2% | -76↑27.3% | -104↓20.0% | -87 | |
| Bottom-Line Net Income | -205↑64.0% | -568↓649.2% | -76↑27.3% | -104↓20.0% | -87 | |
| EPS (Basic) | -0.60↑71.6% | -2.11↓502.9% | -0.35↑27.1% | -0.48↓9.1% | -0.44 | |
| EPS (Diluted) | -0.60↑71.6% | -2.11↓502.9% | -0.35↑27.1% | -0.48↓9.1% | -0.44 | |
| Weighted Average Shares | 342↑27.1% | 269↑22.8% | 219↑1.0% | 217↑9.5% | 198 | |
| Weighted Average Diluted Shares | 342↑27.1% | 269↑22.8% | 219↑1.0% | 217↑9.5% | 198 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.